Cardio Diagnostics, Inc, a biotechnology company making cardiovascular disease prevention and early detection more accessible, personalized and precise, announces the launch of its patent-pending ...

CMS released proposals to update cardiovascular disease risk assessment and risk management services. The organization proposed coding and payment for an atherosclerotic cardiovascular disease risk ...

The 10-year risk estimates for major adverse cardiovascular events underestimate the 20-year cardiovascular burden by nearly three- to tenfold, with the increase in events between 10 and 20 years ...

Risk prediction has been used in the primary prevention of cardiovascular disease for >3 decades. Contemporary cardiovascular risk assessment relies on multivariable models, which integrate ...

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company’s clinical blood test, Epi+Gen CHD ...

Comprehensive Cloud-Based Platform Combines AI Diagnostics and Detailed Measurements for Rapid and Accurate Diagnosis of Structural Heart Disease and Heart Failure BOSTON--(BUSINESS WIRE)--AISAP, a ...

Chronic kidney disease (CKD) is a strong cardiovascular risk factor and is often accompanied by hypertension and diabetes. Despite the disease's prevalence - 10 percent of individuals across the globe ...

Sometimes, a study on one topic can reveal important issues in another. Case in point: A recent Lancet study explored what a person’s life was like before they developed chronic pain — the diseases ...

Please provide your email address to receive an email when new articles are posted on . Cardiovascular risk assessments used in the general population did not accurately predict risk among men with ...